Induction Chemotherapy Fails to Offer Survival Benefit in Head and Neck Cancer

Negative phase III trial results bring into question the use of neoadjuvant chemotherapy for the management of locally advanced head and neck cancer...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.